Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Day One Biopharmaceuticals, Inc. - Common Stock (NQ:DAWN)

9.575 -0.025 (-0.26%)

Streaming Delayed Price Updated: 2:26 PM EST, Dec 26, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	309,477
Open	9.580
Bid (Size)	9.570 (800)
Ask (Size)	9.580 (1,600)
Prev. Close	9.600
Today's Range	9.450 - 9.650
52wk Range	5.635 - 13.53
Shares Outstanding	73,572,633
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 16, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting

November 24, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Performance

YTD	-24.7%	-24.7%
1 Month	+1.5%	+1.5%
3 Month	+43.3%	+43.3%
6 Month	+47.8%	+47.8%
1 Year	-25.8%	-25.8%

More News

Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference

November 18, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Mersana Therapeutics Stock Explodes Over 200% To Notch Best Day Ever As $285M Buyout Trumps Analyst Downgrades: Retail Cheers ‘Very Good Bargain’ ↗

November 14, 2025

Via Stocktwits

Day One Biopharma Expands Oncology Pipeline With $285 Million Mersana Buyout ↗

November 13, 2025

Via Benzinga

Mersana Catapults 200% On Day One Bio's Surprise Buyout ↗

November 13, 2025

Via Investor's Business Daily

MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal ↗

November 13, 2025

Via Stocktwits

Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases

November 13, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Day One Announces New OJEMDA™ (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting

November 10, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Keep an eye on the top gainers and losers in Wednesday's session. ↗

November 05, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 05, 2025

Via Benzinga

Day One Reports Third Quarter 2025 Financial Results and Corporate Progress

November 04, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025

October 21, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

August 06, 2025

Via Benzinga

Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket ↗

August 06, 2025

Via Benzinga

Day One (DAWN) Q2 Revenue Jumps 313% ↗

August 05, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 05, 2025

Via Benzinga

Day One Biopharmaceuticals Inc (NASDAQ:DAWN) Reports Q2 2025 Earnings: Revenue Growth but Wider-Than-Expected Loss ↗

August 05, 2025

Via Chartmill

Day One Reports Second Quarter 2025 Financial Results and Corporate Progress

August 05, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025

July 22, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development

June 10, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Day One Reports First Quarter 2025 Financial Results and Corporate Progress

May 06, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Day One Biopharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Day One Biopharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Day One Biopharmaceuticals, Inc. - Common Stock trade on?

Day One Biopharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Day One Biopharmaceuticals, Inc. - Common Stock?

The ticker symbol for Day One Biopharmaceuticals, Inc. - Common Stock is DAWN on the Nasdaq Stock Market

What is the current price of Day One Biopharmaceuticals, Inc. - Common Stock?

The current price of Day One Biopharmaceuticals, Inc. - Common Stock is 9.575

When was Day One Biopharmaceuticals, Inc. - Common Stock last traded?

The last trade of Day One Biopharmaceuticals, Inc. - Common Stock was at 12/26/25 02:26 PM ET

What is the market capitalization of Day One Biopharmaceuticals, Inc. - Common Stock?

The market capitalization of Day One Biopharmaceuticals, Inc. - Common Stock is 704.46M

How many shares of Day One Biopharmaceuticals, Inc. - Common Stock are outstanding?

Day One Biopharmaceuticals, Inc. - Common Stock has 704M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.